Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Australia's Therapeutic Goods Administration (TGA) classified it as safe
Potential pancreatitis risk : As with other GLP-1-based therapies, there is a theoretical concern regarding pancreatitis, though causality has not been firmly established in trials to date
Tier 3: Targeted Fat-Cell Peptides
The incretins have far stronger and more mature human clinical data
This injection helped straight away
Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
US$ 27.59
US$ 28.33
US$ 25.91
US$ 27.18
US$ 29.35
US$ 21.54
US$ 27.79
US$ 20.63
